Valley Cottage, NY, United States of America

Steven C Leiser

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Steven C Leiser: Innovator in Heteroaromatic NMDA Receptor Modulators

Introduction:

In the world of pharmaceutical innovation, there are individuals who dedicate their careers to creating groundbreaking solutions for the treatment of various disorders and diseases. One such innovator is Steven C Leiser, a highly skilled inventor based in Valley Cottage, NY (US). In this article, we will explore his latest patents, career highlights, and notable collaborations in the field of heteroaromatic NMDA receptor modulators.

Latest Patents:

Steven C Leiser has been granted three patents, with his latest contributions focusing on heteroaromatic NMDA receptor modulators. Specifically, he has patented 5-(3-chloro-4-fluorophenyl)-7-cyclopropyl-3-(2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one and pharmaceutically acceptable salts thereof. These compounds have shown potential in the treatment of psychiatric, neurological, and neurodevelopmental disorders, as well as diseases of the nervous system.

Career Highlights:

Steven C Leiser is currently associated with Cadent Therapeutics, Inc., a prominent pharmaceutical company specializing in the development of innovative therapies. His expertise and contributions in the field of heteroaromatic NMDA receptor modulators have made him a valuable asset to the company. Through his research and inventions, Steven has demonstrated a deep understanding of the intricacies of the nervous system and its disorders.

Collaborations:

In his journey as an inventor, Steven C Leiser has collaborated with esteemed professionals in the field. Noteworthy among his coworkers are David R Anderson and Robert A Volkmann. Their combined expertise and collaboration have fueled innovative thinking and have further propelled advancements in the realm of NMDA receptor modulators.

Conclusion:

Steven C Leiser's work in the development of heteroaromatic NMDA receptor modulators showcases his commitment to improving the lives of individuals affected by psychiatric, neurological, and neurodevelopmental disorders. Through his patents and valuable contributions to Cadent Therapeutics, Inc., he continues to make significant strides in the field of pharmaceutical innovation. We anticipate that Steven and his collaborators will continue to drive advancements in the treatment of diseases of the nervous system, bringing hope and relief to countless individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…